Clinical Trials Directory

Trials / Completed

CompletedNCT03889145

A Study to Evaluate the Drug-drug Interaction Between Telmisartan, Amlodipine and Hydrochlorothiazide

A Randomized, Open-label, Single Dose, 3-way Crossover Study to Evaluate the Drug-drugs Interaction Between Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
IlDong Pharmaceutical Co Ltd · Industry
Sex
Male
Age
20 Years – 55 Years
Healthy volunteers
Accepted

Summary

A randomized, open-label, single dose, 3-way crossover study to evaluate the drug-drugs interaction between Telmisartan, Amlodipine and Hydrochlorothiazide in healthy male volunteers

Conditions

Interventions

TypeNameDescription
DRUGTelmisartan 80mgTelmisartan 80mg
DRUGAmlodipine10mgAmlodipine 10mg
DRUGHydrochlorothiazideHydrochlorothiazide 25mg

Timeline

Start date
2013-12-19
Primary completion
2014-02-19
Completion
2014-02-19
First posted
2019-03-26
Last updated
2019-03-26

Source: ClinicalTrials.gov record NCT03889145. Inclusion in this directory is not an endorsement.